MESO vs Peers Stock Comparison

Mesoblast Prices as of Oct 26, 2026 Peers: Industry group
MESO Mesoblast Ltd
$12.39 -18.1% 1M -26.3% 1Y
Market cap
$1.60B
P/E
–
Revenue (TTM)
—
Div. yield
–
Gene and Cell Therapy Healthcare

Percentile Scorecard

MESO

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisMESO
Valuation 62 #104 of 275
Growth –
Profitability –
Financial Health 48 #156 of 296
Shareholder Returns –
Overall –
  • MESO ranked among 305 companies in Pharmaceuticals and Biotechnology

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodMESOSPY
1 month -18.1% -0.8%
3 months -14.9% +3.5%
6 months -19.2% +7.0%
Year to date -31.3% +12.2%
1 year -26.3% +13.0%
3 years +429.5% +86.3%
3 years, per year +74.4% +23.1%
5 years +2.2% +68.6%
5 years, per year +0.4% +11.0%
10 years +52.6% +258.0%
10 years, per year +4.3% +13.6%

Risk

MeasureMESOSPY
Volatility, 1Y 54.6% 12.7%
Downside volatility, 1Y 54.9% 12.7%
Beta vs S&P 500, 1Y 1.50 1.00
Return / volatility, 1Y -0.48 1.02
Max drawdown, 5Y -87.9% -25.4%
From 52-week high -40.9% -1.8%
52-week high $20.96 $779.14
52-week low $11.95 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleMESO
P/E now vs peer median -27.9xmedian 10.4x
P/S now vs peer median 13.3xmedian 6.4x
EV/EBITDA now vs peer median —median 10.7x
P/FCF now vs peer median -35.9xmedian 12.5x
P/B now vs peer median 2.8xmedian 1.6x
PEG now vs peer median —median 0.29

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsMESO
Cash & equivalents $102.91M
Total debt $119.24M
Shares (diluted) 129.49M
Enterprise value $1.17B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricMESO
P/E -27.9x
P/FCF -35.9x
P/Operating cash flow –
P/S 13.3x
P/B 2.8x
P/Tangible book 2.8x
EV/EBITDA –
EV/EBIT –
EV/Revenue –
EV/FCF –
EV/Operating cash flow –
PEG (3Y EPS CAGR) –

Growth

14 metrics
MetricMESO
Revenue growth (1Y) –
Revenue CAGR (3Y) –
Gross profit growth (1Y) –
Gross profit CAGR (3Y) –
Operating income growth (1Y) –
Operating income CAGR (3Y) –
Net income growth (1Y) –
Net income CAGR (3Y) –
EPS growth (1Y) –
EPS CAGR (3Y) –
Operating cash flow growth (1Y) –
Operating cash flow CAGR (3Y) –
Free cash flow growth (1Y) –
Free cash flow CAGR (3Y) –

Profitability

14 metrics
MetricMESO
Gross margin –
EBITDA margin –
Operating margin –
Pretax margin –
Net margin –
FCF margin –
Operating cash flow margin –
Return on equity –
Return on assets –
Return on invested capital –
Return on capital employed –
Asset turnover –
Cash conversion (OCF / net income) –
Stock comp / revenue –

Financial Health

11 metrics
MetricMESO
Debt / assets 15.4%
Debt / equity 0.2x
Net debt / EBITDA –
Debt / FCF –
Liabilities / assets 26.5%
Equity / assets 73.5%
Interest coverage –
Current ratio 2.4x
Quick ratio 2.0x
Cash ratio 1.3x
Altman Z-score –

Shareholder Returns

7 metrics
MetricMESO
Dividend yield –
Net buyback yield –
Shareholder yield –
Payout ratio (earnings) –
Payout ratio (FCF) –
Dividend growth (1Y) –
Dividend CAGR (3Y) –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusMESO
EPS, next fiscal year $-0.15FY2027
Revenue, next fiscal year $188.99MFY2027
Revenue growth, next FY +57.2%FY2027
Revenue growth, the year after +110.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersMESO
Held by institutions 3.0%
Institutions holding 73
Change in shares held, QoQ +17.7%
Institutions buying 34
Institutions selling 20
Buyers to sellers 1.70

Add a Peer

Largest companies in the same industry

Related Comparisons

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.